Replikins develops and markets forecasting tools and synthetic vaccines to fight virulent rapidly replicating diseases including bird flu, malaria, and HIV.
|Primary Business Focus||Biotechnology - Pharmaceutical|
|Foreign Distribution||Subscriber access only|
|Samuel Bogoch||Chairman||email available to subscribers|
* Downloads will not contain Personnel E-mail addresses
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of American City Business Journals.